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Utility of cardiac biomrkers study for the earlier diagnosis and follow-
up of anthracyclines –induced cardiotoxicyty in child
Alexandru Grigore Dimitriu 
Iere Clinique de Pediatrie, Iasi, Roumanie
Objectives: Early detection of anthracyclines–induced cardiotoxicity in
child with malignant disease by specific biomarkers: B-type natriuretic peptide
(BNP) and cardiac troponin I (cTnI) and to establish IECA efficacy in treat-
ment of this cardiotoxicity.
Methods: The authors was evaluated 27 patients (3-18 years old), from Pedi-
atric Oncology by clinical exam;ECG; chest X-ray, echocardiography (Echo),
cardiac biomarkers: BNP,cTnI and cardiac enzymes: ASAT,ALAT,CPK.
Patients were divided into 3 groups (A,B,C):A-11 new cases of childhood
cancer; B-10 children on treatment with enalapril for cardioprotection; C-6 chil-
dren with chemotherapeutic protocol completed, without cardioprotector treate-
ment. Patients monitorisation: differently depending on the subgroup studied.
Results: Clinical manifestations: heart failure (1 case), untypical clinic
signs (mild dyspnea, fatigue, asthenia, palpitations):15 cases; Echo : sugges-
tive modifications for cardiotoxicity:6 cases (22,2%): diastolic dysfunction of
the left ventricle(LV)(5), systolic dysfunction LV- 1case ; ECG changes:
sinusal tachycardia, minor ventricular repolarization disturbances. High values
of plasma BNP (cutt-off value – 100pg/ml) were highlighted in 11 patients:
values 100-200 pg/ml=4 and >200pg/ml=7.cTnI values: all cases was situated
under the cutt-off value of 0.4 ng/mL.Increased values of plasma BNP was
directly correlated with cumulative dose of antraciclines All children on car-
dioprotector treatment had normal values of BNP and cTnI. Any changes of
ASAT, ALAT, CPK weren’t correlated with changes in the BNP and cTnI
values.Conclusions.
The results proved the utility of research of cardiac specific biomarkers for
early detection of anthracyclines–induced cardiotoxicity, the correlation with
stage of disease treatment and cumulative dose and the suggestive Echo
changes for cardiac involvement, the favorable cardioprotector effect of enal-
april in prevention and treatment of this cardiotoxicity.
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“Grey Zone” of 40-50% ejection fraction in ambulatory patient with
Heart Failure. Who are these patients? Lessons from the DEVENIR
study
Alain Cohen Solal (1), Patrick Assyag (2), Pierre Clerson (3), Christine
Contre (4), Maxime Guenoun (5), Pascal Poncelet (5), Jean Francois The-
baut (5), Leurs Irina (4)
(1) LARIBOISIERE, Paris, France – (2) SAINT ANTOINE, Paris, France –
(3) ORGAMETRIE, Roubaix, France – (4) MENARINI, Rungis, France –
(5) CNCF, Paris, France
Rationale: Heart Failure (HF) with preserved LVEF has been individual-
ized in recent years as a specific entity, with different mechanisms, special
baseline characteristics, a poor prognosis and no clearly recognized treatment.
LVEF cut-off has not been clearly defined. If 50% is generally accepted as a
rather specific cut-off, there remains a « grey zone » of patients with EF
between 40% and 50% not clearly individualized between reduced and pre-
served LVEF.
Objectives: to describe the characteristics of patients with LVEF belonging
to the "grey zone" and to compare these patients to those with either reduced
or preserved LVEF.
Methods: Cross sectional observational survey with retrospective collec-
tion of data at hospital discharge. Patients must have been diagnosed with HF
and have been hospitalized for HF within the previous 18 months. Patients are
classified according to the LVEF at hospital discharge.
Results: 412 French outhospital cardiologists included 1 452 patients with
the inclusion criteria.
Conclusion: This is the first French survey in patients managed by cardi-
ologists after hospital discharge for HF. Cardiologists mainly care for patients
with low LVEF. Overall, the profile of patients with LVEF 40-50% at hospital
discharge is closer to the < 40% than to the >50% LVEF group. Characteris-
tics according to LVEF at discharge (n=1 408) are displayed below.
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Objective: the objective was to identify the epidemiological, clinical and
the outcome of heart failure (HF) in a Moroccan hospital.
Method: A retrospective study using a serie of 294 patients hospitalized in
our service from January 2005 to December 2008.
Results: The HF occupies 14% of hospitalizations. The mean length of stay
was 14 ± 3.1 days. The mean age was 58 ± 11.5 years. Men were mostly repre-
sented with a ratio H / F = 3.5. The main cardiovascular risk factor was smoking
(55%) followed by hypertension (40%) and diabetes (35%). Dyspnea was the main
symptom reported in 91% of the cases. The clinical presentation was that of left
(65%), right (22%) and global(23%) HF. Among electric signs, we found Atrial
fibrillation (30%), a Q-wave (58%) and left ventricular hypertrophy (28%). the
chest x-ray showed a cardiomegaly (89%) and signs of pulmonary overload
(86%). Biology showed electrolyte abnormalities in half of the cases, renal failure
(35%) and anemia (28%). In echocardiography, the mean left ventricular ejection
fraction (LVEF) was 34.5 ± 5.4%. LVEF was > 45% for 26% of patients. 134
patients underwent a coronary angiography which objectified coronary damage in
84% of the cases. The main causes were ischemic heart disease (42%), valvular
heart disease(24%) and hypertension (13%). most used drugs were angiotensin
converting enzym inhibitors and diuretics. 21% of patients underwent a mitral
valve replacement with mechanical prosthesis. Among patients with coronary
artery disease, 33% were revascularized by coronary bypass (21%) and coronary
angioplasty (12%). Cardiac resynchronization was performed for 19 patients using
implantable automatic defibrillator for 3 of them.Hospital mortality was 10%.
Conclusion: The main features of this population is the relatively young
age, male predominance, ischemic heart disease as a leading cause and low
rate of HF with preserved systolic function.
Table. Patients characteristics according to EF
LVEF<40% 
n=792
LVEF 40-50% 
n=366
LVEF>50% 
n=250 P
Age 71±12 73±11† 76±11 0,0001
Men 74% 65% 47% 0,0001
Ischemic etiology 53% 55%†* 42% 0,003
Hypertensive etiology 30% 51%† 64% <0,0001
Valvular etiology 12% 17%†* 25% <0,0001
Dilated 
cardiomyopathy
44% 25%†* 8% <0,0001
Renal dysfunction 37% 34%† 27% 0,01
Sinus rhythm 71% 69%† 60% 0,008
Discharge BNP 
(pg/ml)
439 325 320 0,01
DischargeNYHA 
class III-IV
41% 29%†* 21% <0,0001
p by ANOVA with Bonferroni correction; 
†p<0,05 for comparisons between "grey zone" and LVEF>50%; 
*p<0,05 for comparisons between "grey zone" and LVEF<40%. 
Comparisons for age adjusted for sex.
